Joel Greenblatt · Magic Formula: high return on capital at a cheap EV/EBIT
Is Aurinia Pharmaceuticals Inc. (AUPH) a Joel Greenblatt Stock?
Partial match: either cheap or high-quality, but not both.
63/100
Mixed
2/5 criteria passed
Joel Greenblatt's Criteria, Applied to AUPH
EBIT/EV yield ≥ 10%
key5.2%
ROIC ≥ 25%
key19.0%
EV/EBIT ≤ 12
19.1x
Gross margin ≥ 30%
89.7%
How AUPH Scores on Other Strategies
Live Financial Snapshot
Market cap
$2.29B
P/E (TTM)
6.8x
ROIC (TTM)
18.99%
Gross margin
89.74%
Other Joel Greenblatt fit reports
Frequently Asked Questions
What is AUPH's Joel Greenblatt fit score?
AUPH scores 63/100 on our Joel Greenblatt fit engine. Partial match: either cheap or high-quality, but not both.
Does Joel Greenblatt actually own AUPH?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends AUPH.
How often is this score updated?
AUPH's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends AUPH.
